?1 prior routine of chemotherapy for Highly developed breast cancer and over the full demo, prior exposure to any FGFR inhibitor, significant surgery or radiotherapy within just 4 months ahead of first dose of examine treatment and using potent inhibitors or inducers of CYP3A4 or CYP2D6. Any of the following cardiac standards precluded people enter